Gsk

(Image: Getty/Tetiana Lazunova)

Pharma takes interest in genomics to next level

By Ben Hargreaves

Four pharma companies are providing half of the investment required for ‘world’s largest genetics project’, in return for access to the genomic data generated.

(Image: Getty/Esben_H)

Vaccine investment breathing new life into space?

By Ben Hargreaves

Once a neglected area of pharma research, companies are now investing heavily after several major commercial successes and with promising new avenues of research progressing.

Valneva-GSK sever vaccine alliance

GSK-Valneva end legacy vaccines partnership

By Ben Hargreaves

GSK and Valneva have come to a mutual early termination agreement, as the former looks to ‘allocate capital to fewer, highest priority areas’.